¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acute hepatitis B without delta- agent with hepatic coma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº
  • acute renal failure
    ±Þ¼ºÄáÆÏ±â´É»ó½Ç, ±Þ¼º½ÅºÎÀü
  • acute respiratory distress syndrome
    ±Þ¼ºÈ£Èí°ï¶õÁõÈıº
  • acute situational stress reaction
    ±Þ¼º»óȲ½ºÆ®·¹½º¹ÝÀÀ
  • acute spasmodic laryngitis
    ±Þ¼º¿¬ÃàÈĵο°
  • acute tonsillitis
    ±Þ¼ºÆíµµ¿°
  • acute transverse myelitis
    ±Þ¼ºÈ¾´Üô¼ö¿°, ±Þ¼º°¡·Î¹æÇâô¼ö¿°
  • acute tuberculosis
    ±Þ¼º°áÇÙ
  • acute tubular necrosis
    ±Þ¼º¿ä¼¼°ü±«»ç
  • acute undifferentiated leukemia
    ±Þ¼º¹ÌºÐÈ­¹éÇ÷º´
  • acute urinary retention
    ±Þ¼º¼Òº¯Á¤Ã¼, ±Þ¼º¿äÁ¤Ã¼
  • severe acute respiratory syndrome
    ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
  • anorectic agent
    ½Ä¿å¾ïÁ¦Á¦
  • antiallergic agent
    ¾Ë·¹¸£±â¾à
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • bacteriostatic agent
    Á¤±ÕÁ¦
  • biologic agent
    »ý¹°ÇÐÀûÁ¦Á¦
  • blocking agent
    Â÷´ÜÁ¦
  • bulking agent
    ÀåÈ®À强¾à¹°
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
  • carcinostatic agent
    Á¦¾ÏÁ¦
  • cardioactive agent
    ½ÉÀåÀÛ¿ë¾à
  • cardiotonic agent
    °­½ÉÁ¦
  • causative agent
    º´¿øÃ¼, ¿øÀι°Áú
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦
  • cholinergic agent
    Äݸ°¼º¾à¹°
  • cholinergic blocking agent
    Äݸ°Â÷´ÜÁ¦
  • compounding agent
    ¹èÇÕÁ¦, Á¶ÇÕÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • cryoprotective agent
    µ¿ÇعæÁöÁ¦, ³Ãµ¿»óÇØ¹æÁöÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • inotropic agent
    ¼öÃàÃËÁøÁ¦(¡­ð¥).
  • physical agent
    ¹°¸®Àû ÀÎÀÚ(Úª×âîÜ ì×í­)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦.
  • protective agent
    º¸È£¾à, ÇÇÆ÷¾à(̰̰Ëâ).
  • psychedelic agent
    ȯ°¢Á¦.
  • psychotropic agent =psychotrotropic
    Á¤½ÅÀÛ¿ë¾à(¡­íÂéÄå·).
  • radioopaque agent
    ¹æ»ç¼± ºñÅõ°ú¼º Á¦Àç
  • radioprotective agent
    ¹æ»ç¼±¹æÈ£Á¦
  • radiosensitive agent
    ¹æ»ç¼±°¨ÀÛ¹°Áú, -¹Î°¨Á¦
  • receptor blocking agent
    ¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
  • reducing agent
    ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
  • Charcots fever =intermitent hepatic f.
    »þ¸£ÄÚ¿­ ¡ì°£Ç漺 °£¿­¡í.
  • Glucogenesis, hepatic, in diabetesmellitus
    ±Û·çÄÚ¿À½º»ý¼º(ßæà÷), °£(ÊÜ)ÀÇ, ´ç´¢(ÓØÒã)
  • Hepatic encephalopathy
    °£¼º³úº´Áõ(ÊÜàõÒàÜ»ñø)
  • Hepatic glucogenesis, in diabetes mellitus
    °£´ç»ý¼º(ÊÜÓØßæà÷)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • lupoid hepatitis
    ·çÆ÷À̵尣¿°, ³¶Ã¢¾ç°£¿°(³¶Ã¢¾çÊÜæú)
  • lupus hepatitis
    ·çǪ½º°£¿°
  • milkborne infectious hepatitis
    ¿ìÀ¯Àü¿°¼º°£¿°(ËíËôËøËçËÛ˧Ëç).
  • milkborne infectious hepatitis
    ¿ìÀ¯Àü¿°¼º °£¿°(éÚêáîîæøàõÊÜæú).
  • mouse hepatitis
    ¸¶¿ì½º°£¿°(¡­ÊÜæú).
  • murine hepatitis virus
    ¸¶¿ì½º °£¿° ¹ÙÀÌ·¯½º
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°(~ÊÜæú).
  • non-A, non-B, hepatitis=NANBH
    ºñAºñB °£¿°
  • non-A, non-B, non-C hepatitis
    ºñA ºñB ºñC °£¿°
  • post transfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • posttransfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • serum hepatitis
    Ç÷û°£¿°
  • serum hepatitis
    Ç÷û°£¿°(¡­ÊÜæú).
  • serum hepatitis
    Ç÷û¸Å°³°£¿°
  • serum hepatitis
    Ç÷û°£¿°(¡­ÊÜæú)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
DSIP delta sleep-inducing peptide
FIRDA frontal, intermittent delta activity
IGHD immunoglobin delta heavy chain; isolated growth hormone deficiency
OPRD opiate receptor delta
PHKD phosphorylase kinase, delta
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ALA-S delta-Aminolevulinic acid synthetase
ALAS delta-aminolevulinic acid synthase
delta psi electrical potential
AHF Altered hepatic foci
CHF Congenital hepatic fibrosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute alcoholism
    ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶, ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶Áõ£©¾ËÄÝÀÇ ¼·Ãë·Î ÀÎÇØ¼­ »ýü°¡ Á¤½ÅÀû, ½ÅüÀû ¿µÇâÀ» ¹Þ°í ÁÖ·Î Àϰú¼ºÀ¸·Î ÀǽÄÀå¾Ö°¡ »ý±â´Â °Í.

    acute allergic reaction (±Þ¼º °ú¹Î¼º ¹ÝÀÀ

  • acute alveolar injury
    ±Þ¼º ÆóÆ÷ ¼Õ»ó
    ±Þ¼º È£Èí°ï¶õ ÁõÈıºÀÇ ´Ù¸¥ À̸§.
  • acute anxiety neurosis
    ±Þ¼º ºÒ¾È½Å°æÁõ
  • acute apical abscess
    ±Þ¼º Ä¡±Ù´Ü ³ó¾ç
    µ¿ÀǾî=acute alveolar abscess.
  • acute appendicitis
    ±Þ¼º Ãæ¼ö¿°
    1. Ãæ¼ö¿° ȯÀÚÀÇ 50-80%¿¡¼­ ºÐ¼®
  • acute ascending paralysis
    ±Þ¼º »óÇà ¸¶ºñ, ±Þ¼º »óÇ༺ ¸¶ºñ
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶
    ±ÙÀ° »óÈ£ÇùÁ¶°¡ °á¿©µÇ°Å³ª ±ÙÀ°±â´ÉÀÌ ºÒ±ÔÄ¢ÇÏ¿© ¿îµ¿±â´ÉÀÌ »ó½ÇµÇ´Â °Í.
  • acute atrophic candidiasis
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõ
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõÀÇ º´¼Ò´Â ĵµð´Ù °¨¿°ÀÇ ¶Ç ´Ù¸¥ ÇüÅ·μ­ ÈçÇÑ °ÍÀº ¾Æ´Ï´Ù. ÀÌ º´¼Ò´Â ¹Ýµå½Ã µ¿ÀÏ ÇüÅÂÀÇ È¯ÀÚ Áï ±Þ¼º À§¸·¼º ĵµð´ÙÁõÀ¸·Î ÁøÇàµÇ±â ½¬¿î ȯÀÚ¿¡¼­ ³ªÅ¸³­´Ù. ¶Ç ±¤¹üÀ§ Ç×»ýÁ¦ ½ºÅ×·ÎÀ̵å Á¦Á¦ ¶Ç´Â ¸é¿ª ¾ïÁ¦Á¦¸¦ Åõ¿© ¹Þ´Â ȯÀÚ¿¡¼­µµ ³ªÅ¸³­´Ù. Á¶Á÷ Ç¥º»À» º¸¸é Ç¥ÃþºÎ¿¡ ¼Ò¼öÀÇ ±Õ»ç¸¦ °¡Áö´Â À§Ã༺ »óÇǰ¡ ³ªÅ¸³ª°í °íÀ¯ Ãþ¿¡¼­´Â ´ë°³ °æ¹ÌÇÑ ±Þ¼º ¿°Áõ¼º ħÀ±ÀÌ ³ªÅ¸³ª¸ç Ç÷°üÀÇ ¼ö°¡ Áõ°¡ÇÑ´Ù. ĵµð´ÙÁõ ½Ã ³ªÅ¸³ª´Â º´¼Ò´Â ´Ï½ºÅ¸Æ¾ ±¸°­ Çöʾ×À̳ª ±¸°­ Á¤Á¦·Îµµ »ç¿ëµÇ´Â ´Ï½ºÅ¸Æ¾ Á¤Á¦¸¦ »ç¿ëÇØµµ Àß Ä¡À¯µÈ´Ù.
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°
  • acute bacterial meningitis
    ±Þ¼º ¼¼±Õ¼º ³ú¸·¿°
  • acute bacterial sialadenitis
    ±Þ¼º ¼¼±Õ¼º Ÿ¾×¼±¿°
  • acute bleeding
    ±Þ¼º ÃâÇ÷
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • acute bronchitis
    ±Þ¼º ±â°üÁö¿°
    ´Ü±â°£¿¡ ´Ù¼Ò ÁßÁõ °æ°ú¸¦ ÃëÇÏ´Â ±â°üÁöÀÇ ¿°ÁõÀ¸·Î, ¿øÀÎÀº °¨±â¿¡ °É¸®°Å³ª Àڱؼº ¹°ÁúÀÇ ÈíÀÎÀ̳ª ±Þ¼º °¨¿° µîÀ̸ç, ¹ß¿­, È£Èí°ï¶õ, ±âÁú ¹× ±âħ¿¡ µ¿¹ÝÇÏ´Â ÈäºÎ µÎÅë µîÀ» Ư¡À¸·Î ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
lathosterol delta-5-dehydrogenase <enzyme> Forms 7-dehydrocholesterol (cholesta-5,7-dien-3-beta-ol)
Registry number: EC 1.3.3.2
Synonym: 5 alpha-cholest-7-en-3 beta-ol delta-5-dehydrogenase, lathosterol oxidase, lathosterol 5-desaturase
(26 Jun 1999)
left hepatic artery <anatomy, artery> Left branch of proper hepatic artery; terminal branch off proper hepatic artery supplying left lobe of the liver.
Synonym: ramus sinister arteriae hepaticae propriae.
(05 Mar 2000)
left hepatic duct The duct that drains bile from the left half of the liver, including the quadrate lobe and the left part of the caudate lobe.
Synonym: ductus hepaticus sinister.
(05 Mar 2000)
left hepatic veins Veins draining the lateral segments [II & III] of the left lobe of the liver which join to form a single or paired trunk of variable size which usually (90% of the time) merges with that formed by the middle hepatic veins prior to entering the terminal portion of the superior vena cava.
Synonym: venae hepaticae sinistrae.
(05 Mar 2000)
adrenergic blocking agent A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's.
(05 Mar 2000)
adrenergic neuronal blocking agent A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines.
(05 Mar 2000)
agent <pharmacology> Any power, principle or substance capable of producing an effect, whether physical, chemical or biological.
Origin: L. Agens = acting
(18 Nov 1997)
agent, antihypertensive As the name suggests, a drug aimed at reducing high blood pressure (hypertension).
(12 Dec 1998)
agent, anti-infective Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright.
(12 Dec 1998)
Agent Orange An herbicide and defoliant, consisting of (2,4,5-trichlorophenoxy)acetic acid, (2,4-dichlorophenoxy)acetic acid, and dioxin, that was widely used in the Vietnam War; it has been shown to possess residual post-exposure carcinogenic and teratogenic properties in humans.
(05 Mar 2000)
agent, tocolytic A medication that can inhibit labour, slow down or halt the contractions of the uterus. Tocolytic agents are widely used today to treat premature labour and permit pregnancy to procede and so let the foetus gain in size and maturity before being born.
(12 Dec 1998)
alkylating agent <oncology, pharmacology> A reagent that places an alkyl group, for example propyl in place of a nucleophilic group in a molecule. Alkylating reagents include a number of cytotoxic drugs some of which react fairly specifically with N7 of the purine ring and lead to depurination of DNA, for example the agent ethyl ethanesulphonic acid and thus to mutagenesis. The drugs interaction with DNAand prevents the division of the cells.
Examples of drugs include: busulphan, chlorambucil, cyclophosphamide, melphalan.
(29 Sep 1997)
alpha-adrenergic blocking agent An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension.
Synonym: alpha-blocker.
(05 Mar 2000)
antianxiety agent A functional category of drugs useful in the treatment of anxiety and able to reduce anxiety at doses which do not cause excessive sedation (e.g., diazepam).
Synonym: anxiolytic, minor tranquilliser.
(05 Mar 2000)
antidiabetic agent A substance that helps a person with diabetes control the level of glucose (sugar) in the blood so that the body works as it should. See: insulin.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á